In a groundbreaking development, Levita Magnetics has introduced the world to its pioneering MARS (Magnetic-Assisted Robotic Surgery) platform. This announcement comes just over a month after the FDA granted clearance for its commercial use. The system has already demonstrated its potential at the Cleveland Clinic where Dr. Matthew Kroh and Dr. Andrew Strong successfully performed minimally invasive procedures. The significance of this milestone cannot be overstated, as it marks a remarkable leap forward in the realm of abdominal surgeries.
Levita’s MARS system, designed for high-volume abdominal surgeries, harnesses the power of magnets and machines to minimize incisions. It offers precise control during laparoscopic procedures, showcasing the potential to revolutionize how abdominal surgeries are conducted. By utilizing Levita’s proprietary Dynamic Magnetic Positioning technology, MARS is a versatile tool, aiding in a variety of procedures, including laparoscopic bariatric surgeries, gallbladder removals, prostate surgeries, and colorectal procedures. Moreover, its compact design allows it to seamlessly integrate into existing operating rooms.
One of the most compelling aspects of the MARS system is its patient-centric benefits. Patients can look forward to faster recovery times, reduced pain, and fewer visible scars, thanks to the system’s surgeon-controlled arms. With these arms, surgeons gain full control over laparoscopic views and magnetic retractors, eliminating the need for additional assistants. This advancement not only enhances the surgeon’s experience but also ultimately improves patient outcomes.
Dr. Alberto Rodriguez-Navarro, the founder and CEO of Levita Magnetics, emphasized the significance of this groundbreaking technology in the field of abdominal surgery. He envisions the MARS system as a pivotal player in transitioning high-volume abdominal procedures towards ambulatory or same-day discharge settings. Levita’s MARS system is at the forefront of a transformative shift in how high-volume minimally invasive abdominal surgeries are conducted in the United States and around the world, promising better control, visualization, and a more patient-friendly approach to surgical procedures. This marks a profound leap towards reshaping the landscape of abdominal surgery, promising a brighter and more efficient future for healthcare institutions, surgeons, and patients alike.
Key Highlights:
- Levita Magnetics’ Groundbreaking System: Levita Magnetics introduced the world to its MARS (Magnetic-Assisted Robotic Surgery) platform, a revolutionary system designed to transform abdominal surgeries.
- Successful Procedures at Cleveland Clinic: Dr. Matthew Kroh and Dr. Andrew Strong successfully conducted minimally invasive procedures with the MARS system at the Cleveland Clinic, demonstrating its effectiveness in real-world surgical settings.
- FDA Clearance: The MARS system received FDA clearance just over a month before its successful use, highlighting its rapid progress in the medical field.
- Minimizing Incisions: MARS combines magnets and machines to reduce the number of incisions required for abdominal surgeries, promising a less invasive approach for patients.
- Versatile Applications: The system is versatile, assisting in various procedures including laparoscopic bariatric surgeries, gallbladder removals, prostate surgeries, and colorectal procedures.
- Patient-Centric Benefits: MARS offers patients faster recovery, reduced pain, and fewer visible scars. Surgeon-controlled arms provide enhanced control and visualization, reducing the need for additional surgical staff.
- CEO’s Vision: Dr. Alberto Rodriguez-Navarro, the CEO of Levita Magnetics, envisions the MARS system as a game-changer in transitioning high-volume abdominal procedures towards ambulatory or same-day discharge settings.
- Future of Abdominal Surgery: Levita’s MARS system promises to reshape the landscape of abdominal procedures, offering a brighter and more efficient future for healthcare institutions, surgeons, and patients.
References: [1].
